Literatur
- 1
McEwen A, West R, Owen L.
General practitioners view on the provision of Nikotine replacement therapy and bupropion.
BMC Fam Pract.
2001;
2
6
- 2 Statistisches Bundesamt (Hrsg) .Stuttgart: Metzler-Poeschel 2000
- 3
Peto R, Lopez A D, Boreham J. et al .
Mortality from tobacco in developed countries: indirect estimation from national vital
statistics.
The Lancet.
1992;
339
1268-1278
- 4 Jahrbuch Sucht 2003. Geesthacht: Neuland 2003
- 5
Silagy C, Formica N.
Place of bupropion in smoking cessation therapy.
Lancet.
2001;
357
1550
- 6
Pauwels R A, Buist A S, Calverley P M. et al .
Global strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease. National Heart, Lung and Blood Institute/World Health Organization
Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Workshop summary.
Am J Respir Crit Care Med.
2001;
163
1256-1276
- 7
Dragnev K H, Stover D, Dimitrovsky E.
Lung cancer prevention.
Lung Cancer Guidelines.
2003;
123
60-71
- 8
Rigotti N A.
Treatment of tobacco use and dependence.
N Engl J Med.
2000;
346
506-512
- 9 Fiore M C, Bailey W C, Cohen S J. et al .Treating tobacco use and dependence. Clinical
practice guidelines. Rockvill (MD): US Department of Health and Human Services. Public
Health Service June 2000
- 10
West R, McNeill A, Raw M.
Smoking cessation guidelines for health professionals: an update.
Thorax.
2000;
55
987-999
- 11 National Institute for Clinical Excellence (NHS) .Guidance on the use of Nikotine
replacement therapy (NRT) and bupropion for smoking cessation. Technology Appraisal;
No. 39 March 2002
- 12
Jarvis J M, McIntyre D, Bates C.
Effectiveness of smoking cessation initiatives.
BMJ.
2002;
324
608
- 13
Lawrence W F, Smith S S, Baker T B. et al .
Does over-the-counter Nikotine replacement therapy improve smokers' life expectancy?.
Tob control.
1998;
7
364-368
- 14
Henningfield J E, Fant R V, Gitchell J. et al .
Tobacco dependence: global public health potential for new medications development
and indications.
Ann NY Acad Sci.
2000;
909
247-256
- 15 Kröger Ch. Raucherentwöhnung in Deutschland. Grundlagen und kommentierte Übersicht. Köln:
BZgA 2000
- 16
Fiore M C, Jorenby D E, Shensky A E. et al .
Smoking status as the new vital sign: effect on assessment and intervention in patients
who smoke.
Mayo Clin Proc..
1995;
70
209-213
- 17
Tomar S L, Husten C G, Manely M W.
Do dentists and physicians advise tobacco users to quit?.
J Am Dent Assoc.
1996;
127 (2)
259-265
- 18
Raw M, McNeill A, West R.
Thorax.
1998;
53 (Suppl 5, Part 2)
1-37
- 19
Butler C C, Pill R, Stott N CH.
Qualitative study of patients' perception of doctors advice to quit smoking: implications
for opportunistic health promotion.
BMJ.
1998;
316
1878-1881
- 20
Prochazka A V.
New developments in smoking cessation.
Chest.
2000;
117
169-175
- 21
Lancaster T, Stead L, Silagy C. et al .
Effectiveness of interventions to help people stop smoking: findings from the Cochrane
Library.
BMJ.
2000;
321
355-358
- 22 Fagerström K, Johnson M. Attitudes, Knowledge and Behaviour of Smokers from Nine
European Countries. GlaxoSmithKline 2002
- 23 SNICAS 2002 .In: Burtke, U. Raucherentwöhnung kommt zu kurz. Eschborn: GOVI-Verlag
2002
- 24
Wittchen H U.
SNICAS-Studie. Raucher und ihre Entwöhnung in der Praxis.
Der Hausarzt.
2002;
8
52
- 25
Prochaska J O, Goldstein M G.
Process of smoking cessation: implications for clinicians.
Clin Chest Med.
1991;
12
727-735
- 26 Bölcskei P L, Hering Th, Urlbauer M. Strukturierte Raucherberatung und Tabakentwöhnung.
Handbuch für Ärzte. München: Institut für Raucherberatung & Tabakentwöhnung, 4 Aufl
2004
- 27
Coleman T.
Smoking cessation: integrating recent advances into clinical practice.
Thorax.
2001;
56
579-582
- 28 Silagy C, Mant D, Fowler G. et al .Nikotine replacement therapy for smoking cessation. In:
The Cochrane Library, Issue 2. Oxford: Update Software 1998
- 29
Jorenby D E, Leischow S J, Nides M A. et al .
A controlled trial of sustained-release bupropion, a Nikotine patch, or both for smoking
cessation.
N Engl J Med.
1999;
340
685-691
- 30
Hurt R D, Sachs D PL, Glover E D. et al .
A comparison of sustained-release bupropion and placebo for smoking cessation.
N Engl J Med.
1997;
337
1195-1202
- 31
Schuurmans M M, Bolliger C T.
Smoking cessation strategies for real-life situations?.
Swiss Med Wkly.
2003;
133
29-30
- 32
Pierce J P, Gilpin E A.
Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking
cessation.
JAMA.
2002;
288
1260-1264
- 33
Bergmann L, Warncke W, Herschel M.
Bupropion SR als Unterstützung in der Raucherentwöhnung rückfälliger Raucher: Ergebnisse
einer offenen multizentrischen Studie in Deutschland.
Pneumologie.
2004;
139
140-146
- 34
Gonzales D H, Nides M A. et al .
Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion:
A randomized placebo-controlled study.
Clin Pharmacol Ther.
2001;
69
438-444
- 35
Hering Th.
Ärztliche Tabakentwöhnung in der pneumologischen Praxis: Möglichkeiten, Chancen und
Grenzen.
Mitteilungsheft des Bundesverbandes der Pneumologen.
2003;
62
8-13
- 36 Stead L F, Lancaster T, Perera R. Telephone counselling for smoking cessation (Cochrane
Review). Oxford: The Cochrane Library Issue 2 2003
- 37
Etter J F, Perneger T V.
Effectiveness of a computer-tailored smoking cessation program. A randomised trial.
Arch Intern Med.
2001;
161
2596-2601
- 38
www.givingupsmoking.co.uk
.
- 39
Parrot S, Godfrey C, Raw M. et al .
Guidance for commissioners on the cost effectiveness of smoking cessation interventions.
Thorax.
1998;
53 (Suppl 5 Part 2)
1-38
Univ. Doz. Dr. med.
Pál L. Bölcskei
Institut für Raucherberatung und Tabakentwöhnung (IRT) München
Limburgstraße 16a
81539 München
Email: boelcskei-irt@rauchfreiwerden.de
